From: The impact of age-related syndromes on ICU process and outcomes in very old patients
Circulatory failure | Combined respiratory/circulatory failure | Emergency surgery | Multitrauma w/wo head injury | Multitrauma without head injury | Other | Respiratory failure | Sepsis (according to Sepsis3) | p-value | ||
---|---|---|---|---|---|---|---|---|---|---|
Invasive MV | yes | 247 (45.7%) | 307 (68.4%) | 307 (56.9%) | 54 (72%) | 36 (41.4%) | 321 (43.2%) | 417 (44.3%) | 264 (49.2%) | < 0.0001 |
Duration IMV (hours) | med (IQR) | 42 (16–96) | 72.5 (29.2–177.5) | 24 (12–95.5) | 120 ( 24.5–245.5) | 91.5(17.75–210.75) | 46 (14–160.25) | 111.5 (36–240) | 75 (24–231) | < 0.0001 |
NIV | yes | 67 (12.4%) | 135 (30.1%) | 64 (11.8%) | 5 (6.8%) | 17 (19.5%) | 48 (6.5%) | 481 (51.2%) | 86 (16%) | < 0.0001 |
Duration NIV (hours) | med (IQR) | 12 (4–32.5) | 21 (6–50.5) | 24 ( 8–44.5) | 22 (20–88) | 12.5 (7.5–35.7) | 20 (7.7–39) | 20 (6–50) | 16 ( 4–56) | 0.2401 |
Tracheostomy | yes | 19 (3.5%) | 41 (9.2%) | 20 (3.7%) | 9 (12%) | 9 (10.3%) | 46 (6.2%) | 85 (9%) | 35 (6.5%) | < 0.0001 |
Vasoactive drugs | yes | 372 (68.8%) | 342 (76.3%) | 363 (67.2%) | 51 (68%) | 43 (49.4%) | 289 (38.9%) | 409 (43.4%) | 460 (85.5%) | < 0.0001 |
Duration vaso active drugs(hours) | med (IQR) | 32 ( 14–69.25) | 52 (20–121) | 35 ( 16–72) | 58(18–109.5) | 45 (24–116) | 35 (13–96) | 60 ( 24–144) | 48 (22–110) | < 0.0001 |
Renal replacement therapy | yes | 50 (9.2%) | 73 (16.3%) | 40 (7.4%) | 6 (8.1%) | 8 (9.2%) | 67 (9%) | 75 (8%) | 110 (20.5%) | < 0.0001 |
Withholding LST | yes | 165 (30.7%) | 142 (32.2%) | 123 (22.9%) | 21 (28.8%) | 20 (23%) | 166 (22.6%) | 314 (33.6%) | 189 (35.7%) | < 0.0001 |
Delay admission withholding decision | med (IQR) | 1 (1–2) | 2 (1–4) | 2 (1–4) | 2 (1–6) | 2 (1–4.5) | 1 (1–3) | 1 (1–4) | 1 (IQR 1–4) | 0.0349 |
Withdrawing LST | yes | 90 (16.7%) | 87 (19.7%) | 55 (10.2%) | 11 (14.9%) | 9 (10.3%) | 87 (11.8%) | 125 (13.4%) | 81 (15.3%) | < 0.0001 |
Delay admission withdrawing decision | med (IQR) | 3 (2–4) | 4(2–6) | 4(2–8) | 5 (2–9) | 9 (2–20) | 3 (1–6) | 5 (2–8) | 3 (2–8) | < 0.0001 |
ICU LOS for non-survivors | med (IQR) | 3 (1.5–5.4) | 4.06 (1.9–8.0) | 3 (1.5–6.7) | 6 (1.9–13.0) | 4.7 (2.2–9.0) | 3 (1.4–6.5) | 5 (2.2–9.9) | 4.75 (2–9.0) | < 0.0001 |
ICU LOS for survivors | med (IQR) | 3 (1.7–5.8) | 4.4 (2–8.6) | 2.9 (1.5–5.0) | 4.8 (1.9–11.9) | 4.44 (2.0–6.9) | 3 (1.6–6.0) | 4.75 (2.2–9.0) | 5 (2.5–8.8) | < 0.0001 |
ICU mortality | n (%) | 151 (28%) | 208 (46.8%) | 110 (20.4%) | 26 (34.7%) | 21 (24.1%) | 145 (19.6%) | 242 (25.8%) | 169 (31.5%) | < 0.0001 |